An Adverse Outcome Pathway Network for Chemically Induced Oxidative Stress Leading to (Non)genotoxic Carcinogenesis

Christina H J Veltman1,2, Jeroen L A Pennings1, Bob van de Water2

  • 1Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands.

Insights

Nongenotoxic carcinogens cause cancer through oxidative stress, not DNA damage. This study presents an adverse outcome pathway network to better detect these chemicals and improve cancer risk assessment.

Area of Science:

  • Toxicology
  • Carcinogenesis
  • Environmental Health

Background:

  • Nongenotoxic (NGTX) carcinogens induce cancer through mechanisms other than direct DNA damage, such as oxidative stress.
  • Current carcinogenicity assessments focus on genetic toxicity, potentially missing NGTX chemicals.
  • Oxidative stress occurs when oxidant levels overwhelm antioxidant capacity, leading to regenerative proliferation and potentially cancer.

Purpose of the Study:

  • To develop an adverse outcome pathway (AOP) network for chemically induced oxidative stress leading to NGTX carcinogenesis.
  • To investigate the role of oxidative stress in cancer hallmarks.
  • To identify mechanisms of chemical induction of oxidative stress and its biological effects.

Main Methods:

  • Literature review and pathway analysis to construct the AOP network.
  • Investigation of oxidative stress in cancer development.
  • Exploration of uncertainties within the AOP network.

Main Results:

  • An AOP network detailing the pathway from chemical-induced oxidative stress to NGTX carcinogenesis was developed.
  • The role of oxidative stress in cancer hallmarks and mechanisms of induction were elucidated.
  • Associated uncertainties in the AOP network were identified.

Conclusions:

  • The developed AOP network provides a mechanism-based approach for assessing NGTX carcinogens.
  • This approach enhances the predictivity of carcinogenicity assessment strategies.
  • Transitioning to mechanism-based, human-relevant assessments using AOPs can reduce animal testing.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.0K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
52